Candriam SCA’s New York Times NYT Stock Holding History

Candriam SCA’s Portfolio NYT Stock Details NYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-12,508	Closed	-$448K	–	825
2023 Q1	$448K	Buy	12,508 +1,704	+16%	+$62.8K	﹤0.01%	791
2022 Q4	$351K	Sell	10,804 -10,656	-50%	-$347K	﹤0.01%	830
2022 Q3	$617K	Buy	+21,460	New	+$656K	﹤0.01%	797
2019 Q3	–	Sell	-14,000	Closed	-$455K	–	794
2019 Q2	$455K	Buy	+14,000	New	+$466K	0.01%	746

Other funds holding NYT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return

Stockbridge Partners Boston, Massachusetts $4.14B AUM 16.9% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

DCP

Darsana Capital Partners New York $4.7B AUM 50.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ROIC

Route One Investment Company San Francisco, California $2.35B AUM 11.7% 1-Year Est. Return

Candriam SCA's NYT Position: Q2 2023 in Review

Candriam SCA sold out of New York Times (NYT) in Q2 2023, closing a stake of 12,508 shares — an estimated $448K sold.

Candriam SCA first reported a position in NYT in Q2 2019 and held it in 4 quarters. The position peaked at $617K in Q3 2022. 340 funds tracked by Wall St. Rank hold NYT as of Q2 2023.

Candriam SCA reported no remaining New York Times position as of Q2 2023 after selling out during the quarter.
Candriam SCA sold 12,508 New York Times shares in Q2 2023, an estimated $448K.
Candriam SCA first reported a position in New York Times in Q2 2019 and held it in 4 quarters.
Candriam SCA's New York Times position peaked at $617K in Q3 2022.
340 funds tracked by Wall St. Rank held New York Times as of Q2 2023.

Based on Candriam SCA's 13F filing for Q2 2023, filed 8 Aug 2023.